Mircescu H, Jilwan J, N'Diaye N, Bourdeau I, Tremblay J, Hamet P, Lacroix A
Department of Medicine, Research Center, H6tel-Dieu du Centre Hospitalier de l'Université de Montréal, Québec, Canada.
J Clin Endocrinol Metab. 2000 Oct;85(10):3531-6. doi: 10.1210/jcem.85.10.6865.
Twenty consecutive patients with adrenal Cushing's syndrome were studied with an in vivo protocol to determine the prevalence and diversity of the presence of ectopic or abnormal hormone receptors in their adrenal tissues. All six patients with bilateral ACTH-independent macronodular adrenal hyperplasia were found to have one or two abnormal adrenal receptors, including those for gastric inhibitory polypeptide, vasopressin (V1-vasopressin), beta-adrenergic agonists, LH/human CG, or serotonin 5-HT4. The presence of abnormal hormone receptors was found to be less frequently present in unilateral adenomas or carcinomas (3 of 14). The identification of abnormal adrenal hormone receptors can allow new pharmacological therapies of hypercortisolism. We suggest that the clinical screening for the presence of abnormal hormone receptors should be conducted in patients with adrenal Cushing's syndrome and, more particularly, in those with ACTH-independent macronodular adrenal hyperplasia, in the hope of offering medical therapy as an alternative to bilateral adrenalectomy.
对20例肾上腺库欣综合征患者进行了一项体内研究方案,以确定其肾上腺组织中异位或异常激素受体的患病率和多样性。所有6例双侧促肾上腺皮质激素非依赖性大结节性肾上腺增生患者均被发现有一到两个异常肾上腺受体,包括胃抑制多肽、血管加压素(V1-血管加压素)、β-肾上腺素能激动剂、促黄体生成素/人绒毛膜促性腺激素或5-羟色胺5-HT4受体。单侧腺瘤或癌中异常激素受体的存在频率较低(14例中有3例)。肾上腺激素异常受体的鉴定可为皮质醇增多症提供新的药物治疗方法。我们建议对肾上腺库欣综合征患者,尤其是促肾上腺皮质激素非依赖性大结节性肾上腺增生患者进行异常激素受体存在情况的临床筛查,以期提供药物治疗作为双侧肾上腺切除术的替代方案。